| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.46B | 37.73B | 37.96B | 37.87B | 35.80B | 31.58B |
| Gross Profit | 10.69B | 10.26B | 11.48B | 11.85B | 9.85B | 8.04B |
| EBITDA | 9.79B | 8.34B | 9.94B | 9.69B | 7.13B | 6.88B |
| Net Income | 4.08B | 4.83B | 4.08B | 4.05B | 3.19B | 2.73B |
Balance Sheet | ||||||
| Total Assets | 84.91B | 85.61B | 82.35B | 78.47B | 74.18B | 72.69B |
| Cash, Cash Equivalents and Short-Term Investments | 12.29B | 15.18B | 12.30B | 14.53B | 18.32B | 17.86B |
| Total Debt | 9.62B | 10.33B | 9.21B | 8.85B | 9.09B | 10.57B |
| Total Liabilities | 22.35B | 22.00B | 21.52B | 20.78B | 20.97B | 20.43B |
| Stockholders Equity | 53.56B | 54.39B | 52.02B | 49.45B | 45.56B | 44.99B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 818.00M | 567.00M | 78.00M | 3.96B | 5.91B |
| Operating Cash Flow | 0.00 | 6.32B | 5.23B | 3.19B | 5.80B | 7.55B |
| Investing Cash Flow | 0.00 | -2.20B | -5.55B | -4.43B | -1.60B | -608.00M |
| Financing Cash Flow | 0.00 | -1.26B | -1.99B | -2.61B | -3.78B | -3.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥26.19B | 6.46 | ― | 3.21% | 9.61% | 173.72% | |
75 Outperform | ¥53.23B | 10.10 | 9.07% | 4.46% | -1.14% | 34.15% | |
73 Outperform | ¥60.42B | 8.68 | ― | 4.32% | -31.99% | -44.75% | |
67 Neutral | ¥67.31B | 10.30 | ― | 2.22% | 5.17% | 79.36% | |
66 Neutral | ¥40.70B | 35.78 | ― | 3.24% | 1.83% | -8.54% | |
63 Neutral | ¥214.69B | 10.31 | 6.95% | 3.06% | -7.36% | -574.56% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |